Table 3.
Correct first-line treatment | Physicians n = 14; n (%) |
Other staff n = 31; n (%) |
Total n = 45; n (%) |
---|---|---|---|
P. vivax a | 4 (28.6) | 7 (22.6) | 11 (24.4) |
P. falciparum b | 4 (28.6) | 5 (16.1) | 9 (20.0) |
P. vivax among pregnant womenc | 1 (7.1) | 3 (9.7) | 4 (8.9) |
P. falciparum during the first trimester of pregnancyd | 1 (7.1) | 1 (3.2) | 2 (4.4) |
P. falciparum during the second and third trimesters of pregnancye | 0 (0.0) | 2 (6.5) | 2 (4.4) |
Treatment for severe malariaf | 0 (0.0) | 2 (6.5) | 2 (4.4) |
aChloroquine–primaquine
bArtemether–lumefantrine and primaquine
cChloroquine
dQuinine–clindamycin
eArtemether–lumefantrine
fArtesunate